论文信息 - Estrogen ‘add‐back’ and lipid profile during GnRH agonist (triptorelin) therapy - 字舞流文

Estrogen ‘add‐back’ and lipid profile during GnRH agonist (triptorelin) therapy

W. Al-Omari | B. Izzat | U. N. Nassir

[1] W. R. Sulaiman,et al. Estrogen and lipid profile in patients with endometriosis treated by GnRH agonist , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[2] M. Dowsett,et al. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. , 1995, Fertility and sterility.

[3] R. Barbieri,et al. Hormone treatment of endometriosis: the estrogen threshold hypothesis. , 1992, American journal of obstetrics and gynecology.

[4] A. Schally,et al. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients. , 1990, Fertility and sterility.